CD300A promotes tumor progression by PECAM1, ADCY7 and AKT pathway in acute myeloid leukemiaXiaogang Sun(Shandong Provincial Hospital), Xin Wang(Beijing Union University)OncotargetJanuary 11, 201810.18632/oncotarget.24164Cited by 19SaveCiteExport RISWatch citationsRelated PapersStat2-Drp1 mediated mitochondrial mass increase is necessary for pro-inflammatory differentiation of macrophages|Redox Biology|2020|151HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment|Theranostics|2021|140